Chemical classes known as HSPC117 inhibitors consist of compounds that interact with cellular pathways or processes to modulate the activity of the protein HSPC117. These inhibitors do not directly bind to HSPC117; instead, they affect various biological pathways that HSPC117 is potentially involved in, such as protein folding, RNA processing, and intracellular signaling cascades. The list of chemicals provided includes inhibitors of key regulatory proteins and enzymes that can indirectly impact HSPC117 function. For instance, Cyclosporin A and Rapamycin are well-known immunosuppressants that inhibit calcineurin and mTOR, respectively. Their action on these pathways can lead to altered phosphorylation states of proteins and affect the signaling pathways that may be critical for HSPC117 function.
Moreover, chemicals like 5-Fluorouracil affect nucleotide metabolism and RNA processing, which are processes where HSPC117 might have a role. Brefeldin A disrupts vesicular trafficking, which could influence the localization and function of HSPC117 within cells. Lastly, U0126 and LY294002 are inhibitors of the MAPK/ERK and PI3K/AKT pathways, respectively, which are important for cell proliferation and survival signaling pathways. These inhibitors can alter the activity of these pathways, potentially leading to a downstream effect on HSPC117's function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Inhibits calcineurin, which can alter phosphorylation states and potentially affect HSPC117. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to FKBP12 and inhibits mTOR, a kinase that can indirectly influence HSPC117 activity. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Binds to HSP90, potentially disrupting its interaction with HSPC117. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
A derivative of geldanamycin, also targeting HSP90 to affect proteins associated with it. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Disrupts proteasomal function, which may affect HSPC117's cellular stability. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, altering protein degradation pathways that can influence HSPC117. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, altering chromatin structure and gene expression affecting HSPC117. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Another histone deacetylase inhibitor which can change transcriptional activity related to HSPC117. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
A nucleotide analog that can disrupt RNA processing, potentially affecting HSPC117's function. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts transport between the endoplasmic reticulum and Golgi, which might affect HSPC117. | ||||||